Immunovant Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jun 22, 2026 FORM 4
4 Jun 16, 2026 FORM 4
144 Jun 15, 2026
4 May 29, 2026 FORM 4
144 May 28, 2026
4 May 22, 2026 FORM 4
4 May 20, 2026 FORM 4
144 May 20, 2026
10-K May 20, 2026 10-K
8-K May 20, 2026 8-K
4 May 1, 2026 FORM 4
144 May 1, 2026
4 Apr 24, 2026 FORM 4
4 Apr 24, 2026 FORM 4
4 Apr 10, 2026 FORM 4
4 Apr 10, 2026 FORM 4
4 Apr 10, 2026 FORM 4
4 Apr 9, 2026 FORM 4
4 Apr 9, 2026 FORM 4
4 Apr 9, 2026 FORM 4
4 Apr 9, 2026 FORM 4
4 Apr 9, 2026 FORM 4
4 Apr 9, 2026 FORM 4
4 Apr 9, 2026 FORM 4
4 Apr 9, 2026 FORM 4
← Newer Page 2 of 26 · 641 filings Older →